Back to Trades
WILSON TROY EDWARD
DirectorCIK 0001589597
Total Volume
$12.0M
13 filings
Purchases
$3.1M
5 buy txns
Sales
$6.2M
11 sell txns
Net Activity
-$3.1M
net sold
Profile
- Filings
- 13
- Buy transactions
- 5
- Sell transactions
- 11
- Companies
- 4
- Active
- 2025–2026
WILSON TROY EDWARD, Director, has filed 13 SEC reports (2025–2026), spread across 4 companies, totaling $12.0M in disclosed volume. Weighing $3.1M bought versus $6.2M sold, the history is net selling. The largest single open-market purchase on record is $1.2M in Kura Oncology, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
13 loaded
| Sep 16 | PBYI PUMA BIOTECHNOLOGY, INC. | WILSON TROY EDWARD | Director | Sell | $45.5K |
| Aug 24 | KURA Kura Oncology, Inc. | WILSON TROY EDWARD | Insider | Buy | $1.2M |
| Aug 17 | KURA Kura Oncology, Inc. | WILSON TROY EDWARD | Insider | Buy | $1.1M |
| Jun 15 | PBYI PUMA BIOTECHNOLOGY, INC. | WILSON TROY EDWARD | Director | Sell | $77.7K |
| Mar 25 | KURA Kura Oncology, Inc. | WILSON TROY EDWARD | Insider | Exercise | $75.1K |
| Mar 2 | RNA Atrium Therapeutics, Inc. | WILSON TROY EDWARD | Insider | Award | $295.0K |
| Feb 27 | RNAM Avidity Biosciences, Inc. | WILSON TROY EDWARD | Insider | Disposed | $1.3M |
| Feb 26 | RNA Atrium Therapeutics, Inc. | WILSON TROY EDWARD | Insider | Other | $0 |
| Sep 29 | KURA Kura Oncology, Inc. | WILSON TROY EDWARD | Insider | Sell | $327.4K |
| Sep 9 | RNA Avidity Biosciences, Inc. | WILSON TROY EDWARD | Director | Sell | $1.5M |
| Sep 9 | KURA Kura Oncology, Inc. | WILSON TROY EDWARD | Insider | Buy | $410.1K |
| Aug 14 | KURA Kura Oncology, Inc. | WILSON TROY EDWARD | Insider | Buy | $303.2K |
| Aug 8 | RNA Avidity Biosciences, Inc. | WILSON TROY EDWARD | Director | Sell | $4.3M |
13 filings